| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| T Antill, A Jakkoju, J Dieguez, L Laskhmiprasa. LACTIC ACIDOSIS: A RARE MANIFESTATION OF SYNTHETIC MARIJUANA INTOXICATION. The Journal of the Louisiana State Medical Society : official organ of the Louisiana State Medical Society. vol 167. issue 3. 2017-09-28. PMID:27159480. |
synthetic cannabinoids are designer drugs that mimic the effect of cannabis, which has become popular with young drug users. |
2017-09-28 |
2023-08-13 |
human |
| T Antill, A Jakkoju, J Dieguez, L Laskhmiprasa. LACTIC ACIDOSIS: A RARE MANIFESTATION OF SYNTHETIC MARIJUANA INTOXICATION. The Journal of the Louisiana State Medical Society : official organ of the Louisiana State Medical Society. vol 167. issue 3. 2017-09-28. PMID:27159480. |
synthetic cannabinoids cause effects similar to marijuana making the subjects euphoric. |
2017-09-28 |
2023-08-13 |
human |
| Roberta Pacifici, Emilia Marchei, Francesco Salvatore, Luca Guandalini, Francesco Paolo Busardò, Simona Pichin. Evaluation of cannabinoids concentration and stability in standardized preparations of cannabis tea and cannabis oil by ultra-high performance liquid chromatography tandem mass spectrometry. Clinical chemistry and laboratory medicine. vol 55. issue 10. 2017-09-25. PMID:28207408. |
evaluation of cannabinoids concentration and stability in standardized preparations of cannabis tea and cannabis oil by ultra-high performance liquid chromatography tandem mass spectrometry. |
2017-09-25 |
2023-08-13 |
Not clear |
| Alyssa S Laun, Zhao-Hui Son. GPR3 and GPR6, novel molecular targets for cannabidiol. Biochemical and biophysical research communications. vol 490. issue 1. 2017-09-22. PMID:28571738. |
among the variety of cannabinoids tested, cannabidiol (cbd), the major non-psychoactive component of marijuana, significantly reduced β-arrestin2 recruitment to both gpr3 and gpr6. |
2017-09-22 |
2023-08-13 |
Not clear |
| Stephanie E Reuter, Jennifer H Marti. Pharmacokinetics of Cannabis in Cancer Cachexia-Anorexia Syndrome. Clinical pharmacokinetics. vol 55. issue 7. 2017-09-21. PMID:26883879. |
similarly, there is a lack of pharmacokinetic data in any population group for the non- tetrahydrocannabinol (thc) and cannabidiol (cbd) cannabinoids (often due to the lack of analytical standards for quantification). |
2017-09-21 |
2023-08-13 |
Not clear |
| Seddon R Savage, Alfonso Romero-Sandoval, Michael Schatman, Mark Wallace, Gilbert Fanciullo, Bill McCarberg, Mark War. Cannabis in Pain Treatment: Clinical and Research Considerations. The journal of pain. vol 17. issue 6. 2017-09-19. PMID:26961090. |
cannabinoids show promise as therapeutic agents, particularly as analgesics, but their development and clinical use has been complicated by recognition of their botanical source, cannabis, as a substance of misuse. |
2017-09-19 |
2023-08-13 |
Not clear |
| Seddon R Savage, Alfonso Romero-Sandoval, Michael Schatman, Mark Wallace, Gilbert Fanciullo, Bill McCarberg, Mark War. Cannabis in Pain Treatment: Clinical and Research Considerations. The journal of pain. vol 17. issue 6. 2017-09-19. PMID:26961090. |
although research into endogenous cannabinoid systems and potential cannabinoid pharmaceuticals is slowly increasing, there has been intense societal interest in making herbal (plant) cannabis available for medicinal use; 23 u.s. states and all canadian provinces currently permit use in some clinical contexts. |
2017-09-19 |
2023-08-13 |
Not clear |
| Seddon R Savage, Alfonso Romero-Sandoval, Michael Schatman, Mark Wallace, Gilbert Fanciullo, Bill McCarberg, Mark War. Cannabis in Pain Treatment: Clinical and Research Considerations. The journal of pain. vol 17. issue 6. 2017-09-19. PMID:26961090. |
expanded research on cannabis is needed to better determine the individual and public health effects of increasing use of herbal cannabis and to advance understanding of the pharmaceutical potential of cannabinoids as medications. |
2017-09-19 |
2023-08-13 |
Not clear |
| Seddon R Savage, Alfonso Romero-Sandoval, Michael Schatman, Mark Wallace, Gilbert Fanciullo, Bill McCarberg, Mark War. Cannabis in Pain Treatment: Clinical and Research Considerations. The journal of pain. vol 17. issue 6. 2017-09-19. PMID:26961090. |
this article reviews clinical, research, and policy issues related to herbal cannabis to support clinicians in thoughtfully advising and caring for patients who use cannabis, and it examines obstacles and opportunities to expand research on the health effects of herbal cannabis and cannabinoids. |
2017-09-19 |
2023-08-13 |
Not clear |
| Ethan B Russ. Beyond Cannabis: Plants and the Endocannabinoid System. Trends in pharmacological sciences. vol 37. issue 7. 2017-09-19. PMID:27179600. |
beyond cannabis: plants and the endocannabinoid system. |
2017-09-19 |
2023-08-13 |
human |
| Ethan B Russ. Beyond Cannabis: Plants and the Endocannabinoid System. Trends in pharmacological sciences. vol 37. issue 7. 2017-09-19. PMID:27179600. |
one of the most versatile in terms of its phytochemistry is cannabis, whose investigation has led directly to the discovery of a unique and widespread homeostatic physiological regulator, the endocannabinoid system. |
2017-09-19 |
2023-08-13 |
human |
| Ethan B Russ. Beyond Cannabis: Plants and the Endocannabinoid System. Trends in pharmacological sciences. vol 37. issue 7. 2017-09-19. PMID:27179600. |
while it had been the conventional wisdom until recently that only cannabis harbored active agents affecting the endocannabinoid system, in recent decades the search has widened and identified numerous additional plants whose components stimulate, antagonize, or modulate different aspects of this system. |
2017-09-19 |
2023-08-13 |
human |
| b' N\\xc3\\xbckhet Alada\\xc4\\x9f-\\xc3\\x87iftdemir, \\xc4\\xb0lay Y\\xc3\\xbccel, R\\xc4\\xb1dvan Duran, \\xc3\\x9clfet Vatansever-\\xc3\\x96zbek, Bet\\xc3\\xbcl Acuna\\xc5\\x9. A new emerging problem in pediatric emergency units: Synthetic cannabinoids. The Turkish journal of pediatrics. vol 58. issue 5. 2017-09-15. PMID:28621089.' |
synthetic cannabinoids or synthetic marijuana derivatives known as "bonzai" in turkey are addictive substances that affect the brain and have serious side effects. |
2017-09-15 |
2023-08-13 |
Not clear |
| Tamás Oláh, Dóra Bodnár, Adrienn Tóth, János Vincze, János Fodor, Barbara Reischl, Adrienn Kovács, Olga Ruzsnavszky, Beatrix Dienes, Péter Szentesi, Oliver Friedrich, László Csernoc. Cannabinoid signalling inhibits sarcoplasmic Ca The Journal of physiology. vol 594. issue 24. 2017-09-14. PMID:27641745. |
cannabinoid signalling inhibits sarcoplasmic ca marijuana was found to cause muscle weakness, although the exact regulatory role of its receptors (cb1 cannabinoid receptor; cb1r) in the excitation-contraction coupling (ecc) of mammalian skeletal muscle remains unknown. |
2017-09-14 |
2023-08-13 |
Not clear |
| Kimberly A Babson, James Sottile, Danielle Morabit. Cannabis, Cannabinoids, and Sleep: a Review of the Literature. Current psychiatry reports. vol 19. issue 4. 2017-09-14. PMID:28349316. |
cannabis, cannabinoids, and sleep: a review of the literature. |
2017-09-14 |
2023-08-13 |
Not clear |
| Katalin Solymosi, Attila Köfalv. Cannabis: A Treasure Trove or Pandora's Box? Mini reviews in medicinal chemistry. vol 17. issue 13. 2017-09-12. PMID:27719666. |
the female marijuana plant produces a significant quantity of bio- and psychoactive phytocannabinoids, which regained the spotlight with the discovery of the endocannabinoid system of the animals in the early 90's. |
2017-09-12 |
2023-08-13 |
Not clear |
| Florian Franz, Verena Angerer, Hanna Jechle, Melanie Pegoro, Harald Ertl, Georg Weinfurtner, David Janele, Christian Schlögl, Matthias Friedl, Stefan Gerl, Reinhard Mielke, Ralf Zehnle, Matthias Wagner, Bjoern Moosmann, Volker Auwärte. Immunoassay screening in urine for synthetic cannabinoids - an evaluation of the diagnostic efficiency. Clinical chemistry and laboratory medicine. vol 55. issue 9. 2017-08-21. PMID:28130957. |
the abuse of synthetic cannabinoids (scs) as presumed legal alternative to cannabis poses a great risk to public health. |
2017-08-21 |
2023-08-13 |
Not clear |
| Timna Naftali, Refael Mechulam, Amir Marii, Gila Gabay, Asaf Stein, Miriam Bronshtain, Ido Laish, Fabiana Benjaminov, Fred M Konikof. Low-Dose Cannabidiol Is Safe but Not Effective in the Treatment for Crohn's Disease, a Randomized Controlled Trial. Digestive diseases and sciences. vol 62. issue 6. 2017-08-18. PMID:28349233. |
cannabidiol (cbd) is an anti-inflammatory cannabinoid shown to be beneficial in a mouse model of ibd. |
2017-08-18 |
2023-08-13 |
mouse |
| C Michael Whit. The Pharmacologic and Clinical Effects of Illicit Synthetic Cannabinoids. Journal of clinical pharmacology. vol 57. issue 3. 2017-08-16. PMID:27610597. |
although most users prefer using cannabis, there are convenience, legal, and cost reasons driving the utilization of synthetic cannabinoids. |
2017-08-16 |
2023-08-13 |
Not clear |
| C Michael Whit. The Pharmacologic and Clinical Effects of Illicit Synthetic Cannabinoids. Journal of clinical pharmacology. vol 57. issue 3. 2017-08-16. PMID:27610597. |
clinicians should be aware of pharmacologic and clinical similarities and differences between synthetic cannabinoid and cannabis use, the limited ability to detect synthetic cannabinoids in the urine or serum, and guidance to treat adverse events. |
2017-08-16 |
2023-08-13 |
Not clear |